The proposal develops pragmatic actions at the national and multilateral level to expeditiously defeat the pandemic. The benefits of such measures at several trillion dollars far outweigh the cost which was estimated to be around $50 billion.
The following figures and tables track progress on the proposed actions and targets set by IMF Staff Discussion Note – A Proposal to End the COVID-19 Pandemic.
SECURED VACCINES AND/OR EXPECTED VACCINE SUPPLY (DOSES, % OF TOTAL POPULATION)
FULLY VACCINATED COVERAGE AT END-2021 (% OF TOTAL POPULATION)
SHARE OF PEOPLE VACCINATED (2 OR MORE DOSES OF THE COVID-19 VACCINE, % of TOTAL POPULATION)
Cross-Country Distribution of COVAX AMC Deliveries
Source: IMF staff calculations based on UNICEF and COVAX.
Notes: The list includes 88 AMC91 countries who have been allocated doses from COVAX. Two countries are not vaccinating, and the Marshall Islands is covered through other mechanisms. Owing to its size, India has a reduced access as per the December 2020 Board decision. A course equals one dose of J&J or two doses of all other vaccines for comparability. The AMC equal delivery calculation represents the coverage the AMC countries would have received if the total AMC doses were delivered equally across the countries (that is total courses delivered divided by population of the AMC countries represented here).
Illustrative Framework
Source: IMF staff. Notes: The decline in mortality risk is indicative.
Funding Needs by Pillar and Major Outcome Category (in USD billion)
Ratio of Current Cases to 2020 Peak
